Explain and tell what’s the treatment

126766AD-ABC6-4002-B144-69E9CF4C4932.png

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

I now have thorough information from the textbooks to provide a complete, well-sourced answer. Let me compile the full response.

Abdomen Ultrasound Report - Explanation & Treatment

Patient: O. Adi Narayana, 60-year-old Male | Date: 15.07.2026

This is an abdominal ultrasound report with three key findings in the impression. Here is a full breakdown:

Finding 1: Grade I Fatty Liver

What It Means

The liver shows increased parenchymal echogenicity (it appears brighter than normal on ultrasound), which is the hallmark of fat accumulation in liver cells. Grade I means mild fat deposition - the earliest stage of Non-Alcoholic Fatty Liver Disease (NAFLD). The liver size is still normal (13.2 cm), and there are no focal lesions or masses, which is reassuring.

Treatment

The primary goal is to reduce the fat in the liver through lifestyle changes:

Dietary Changes:

Moderate caloric restriction: aim to eat 500-750 kcal less per day
Achieve 5-10% body weight loss - even 5% weight loss improves liver steatosis significantly, and 7-10% loss can improve the full picture of liver inflammation
Reduce or eliminate saturated fats and high-fructose corn syrup (soft drinks, packaged sweets)
Avoid or strictly limit alcohol
Consider 2-3 cups of coffee per day - studies show it reduces risk of liver fibrosis
Mediterranean-style diet may help reduce hepatic steatosis
Omega-3 fatty acids can help reduce triglycerides and hepatic fat

Exercise:

Aerobic and/or resistance training 3-4 times per week, with a goal of expending ~400 kcal per session
Exercise helps even when it does not cause significant weight loss, by improving insulin resistance

Medical Monitoring:

Check fasting blood sugar, HbA1c, and lipid profile - fatty liver is tightly linked to diabetes and high cholesterol
Check and replete Vitamin D if deficient
Liver enzymes (ALT/AST) should be monitored every 6-12 months

Medications (only if lifestyle fails):

Vitamin E 800 IU/day can be considered in non-diabetic patients to reduce liver inflammation
Pioglitazone (if diabetic with NASH) improves liver inflammation but has side effects (weight gain, fluid retention)
Newer agents like GLP-1 agonists (liraglutide, semaglutide) show promise and may be discussed with a physician

Grade I fatty liver is fully reversible with the above lifestyle changes. - Sleisenger and Fordtran's Gastrointestinal and Liver Disease

Finding 2: Cholelithiasis (Gallstone) - No Acute Cholecystitis

What It Means

A single gallstone of 8.7 mm is present in the gallbladder (cholelithiasis). Importantly, there is no evidence of acute cholecystitis - meaning no current infection or active inflammation of the gallbladder wall. The gallbladder wall is smooth and of normal thickness.

This appears to be asymptomatic (silent) cholelithiasis - a very common incidental finding.

Treatment

Based on current surgical guidelines:

If the patient has NO symptoms (no biliary colic, no pain after fatty meals, no nausea/vomiting):

Watchful waiting / expectant management is the recommended approach
Only about 20% of patients with silent gallstones ever develop symptoms over 20 years
The annual risk of developing symptoms is low at about 2-3%
No surgery is needed immediately

Lifestyle Measures:

Low-fat diet to reduce gallbladder stimulation
Weight loss (also beneficial for fatty liver)
Avoid rapid or crash dieting, which paradoxically increases the risk of new stone formation

If the patient develops symptoms (right upper quadrant pain, jaundice, fever):

Laparoscopic cholecystectomy (keyhole surgery to remove the gallbladder) is the gold standard treatment
It is recommended for symptomatic cholelithiasis and complications such as acute cholecystitis, pancreatitis, or obstruction
Current Surgical Therapy 14e; Sleisenger and Fordtran's Gastrointestinal and Liver Disease

Finding 3: Grade I Prostatomegaly with Median Lobe Hypertrophy

What It Means

The prostate is mildly enlarged at 35-36 cc (normal is below 25-30 cc). This is Grade I Benign Prostatic Hyperplasia (BPH) - the most common condition in men over 50. There is median lobe hypertrophy indenting the bladder base, meaning the middle lobe of the prostate is pressing upward into the floor of the bladder. However, the post-void residual urine is only 18 cc (insignificant), which means the bladder is emptying well and there is no significant obstruction at this time.

Treatment

Based on severity of symptoms (IPSS - International Prostate Symptom Score):

Mild/No Symptoms (likely in this patient given normal PVR):

Watchful waiting with regular follow-up
Reduce fluid intake in the evening
Avoid caffeine and alcohol
Bladder training

Moderate Symptoms - Medical Therapy (first-line):

Alpha-blockers (Tamsulosin 0.4 mg once daily, Alfuzosin, Silodosin): These relax smooth muscle in the bladder neck and prostate, reducing urinary obstruction. They work quickly (within days). - Comprehensive Clinical Nephrology
5-alpha reductase inhibitors (Finasteride 5 mg/day, Dutasteride): These block the conversion of testosterone to dihydrotestosterone (DHT), which drives prostate growth. They shrink the gland over 3-6 months. Best suited for larger prostates (>40 cc) or when combined with alpha-blockers.
Combination therapy (alpha-blocker + 5-ARI) is more effective than either drug alone, especially for preventing disease progression.

Surgical Options (if medical treatment fails or complications arise):

TURP (Transurethral Resection of the Prostate) - the gold standard surgical procedure
Also indicated for: urinary retention, recurrent urinary tract infections, bladder stones, or kidney damage from obstruction

Since the patient's post-void residual is only 18 cc (insignificant) and the prostate is only mildly enlarged (Grade I), medical management with watchful waiting or initiation of an alpha-blocker is the appropriate next step, as recommended by a urologist.

Additional Incidental Findings

Finding	What It Means
Right kidney cortical cyst (30x29 mm)	Simple renal cyst - benign, very common. Usually no treatment needed; periodic ultrasound follow-up every 1-2 years
Left kidney cortical cyst (13x12 mm)	Same as above - benign simple cyst, monitor only
Bilateral kidney cysts	No hydronephrosis, normal corticomedullary differentiation - kidneys are functioning well

Summary & Next Steps

Condition	Priority	Action
Grade I Fatty Liver	Address now	Lifestyle changes, blood sugar & lipid check
Gallstone (8.7 mm, asymptomatic)	Monitor	Low-fat diet; surgery only if symptoms develop
Grade I BPH (35-36 cc)	Monitor + consult	Urology consultation; consider tamsulosin if symptoms present
Bilateral simple renal cysts	Monitor	Repeat ultrasound in 1-2 years

This patient should see:

A gastroenterologist or physician for fatty liver management and metabolic workup
A urologist for prostate evaluation and symptom scoring (IPSS questionnaire)
A general surgeon for gallstone surveillance

Disclaimer: This is an educational explanation based on the ultrasound report. Treatment decisions must be made by a qualified physician who has examined the patient and reviewed their full clinical history.

This is a shared conversation. Sign in to Orris to start your own chat.